Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire.
Zepteon, Inc., Boston, Massachusetts.
Biotechnol Bioeng. 2018 May;115(5):1265-1278. doi: 10.1002/bit.26545. Epub 2018 Feb 1.
As antibodies continue to gain predominance in drug discovery and development pipelines, efforts to control and optimize their activity in vivo have matured to incorporate sophisticated abilities to manipulate engagement of specific Fc binding partners. Such efforts to promote diverse functional outcomes include modulating IgG-Fc affinity for FcγRs to alternatively potentiate or reduce effector functions, such as antibody-dependent cellular cytotoxicity and phagocytosis. While a number of natural and engineered Fc features capable of eliciting variable effector functions have been demonstrated in vitro and in vivo, elucidation of these important functional relationships has taken significant effort through use of diverse genetic, cellular and enzymatic techniques. As an orthogonal approach, we demonstrate use of FcγR as chromatographic affinity ligands to enrich and therefore simultaneously identify favored binding species from a complex mixture of serum-derived pooled polycloncal human IgG, a load material that contains the natural repertoire of Fc variants and post-translational modifications. The FcγR-enriched IgG was characterized for subclass and glycoform composition and the impact of this bioseparation step on antibody activity was measured in cell-based effector function assays including Natural Killer cell activation and monocyte phagocytosis. This work demonstrates a tractable means to rapidly distinguish complex functional relationships between two or more interacting biological agents by leveraging affinity chromatography followed by secondary analysis with high-resolution biophysical and functional assays and emphasizes a platform capable of surveying diverse natural post-translational modifications that may not be easily produced with high purity or easily accessible with recombinant expression techniques.
随着抗体在药物发现和开发管道中继续占据主导地位,控制和优化其在体内活性的努力已经成熟,能够结合复杂的能力来操纵特定 Fc 结合伙伴的结合。这种促进多样化功能结果的努力包括调节 IgG-Fc 对 FcγR 的亲和力,以选择性增强或降低效应功能,如抗体依赖性细胞毒性和吞噬作用。虽然已经在体外和体内证明了许多能够引起可变效应功能的天然和工程化 Fc 特征,但通过使用多种遗传、细胞和酶技术,阐明这些重要的功能关系需要付出巨大的努力。作为一种正交方法,我们展示了使用 FcγR 作为色谱亲和配体来富集,从而同时从复杂的血清来源的多克隆人 IgG 混合物中鉴定出首选的结合物种,负载材料包含 Fc 变体和翻译后修饰的天然库。对 FcγR 富集的 IgG 进行了亚类和糖基化形式组成的表征,并在基于细胞的效应功能测定中测量了该生物分离步骤对抗体活性的影响,包括自然杀伤细胞激活和单核细胞吞噬作用。这项工作展示了一种可行的方法,可以通过利用亲和层析,然后通过高分辨率生物物理和功能测定进行二次分析,快速区分两个或更多相互作用的生物制剂之间的复杂功能关系,并强调了一种能够检测可能难以用高纯度生产或难以用重组表达技术获得的多样化天然翻译后修饰的平台。